Role of potassium in acid secretion

World Journal of Gastroenterology

Volumn 11, Issue 34, 2005, Pages 5259-5265

  Geibel, John P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastric H+,K+ ATPase; HCl; Parietal cell; Potassium; Potassium channel; Potassium channel blocker; Potassium competitive acid blocker

Indexed keywords

3 AMINO 5 METHYL 2 (2 METHYL 3 THIENYL)IMIDAZO[1,2 A]THIENO[3,2 C]PYRIDINE; 3 BUTYRYL 8 METHOXY 4 (2 METHYLANILINO)QUINOLINE; 8 BENZYLOXY 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 ACETONITRILE; ANTACID AGENT; AZD 0865; CHROMANOL 293B; CS 526; HYDROCHLORIC ACID; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; INWARDLY RECTIFYING POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KCNQ1; POTASSIUM ION; R 105266; REVAPRAZAN; SORAPRAZAN; UNCLASSIFIED DRUG;

APICAL MEMBRANE; DISEASE SEVERITY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HUMAN; INWARDLY RECTIFYING POTASSIUM CHANNEL KIR2.1; INWARDLY RECTIFYING POTASSIUM CHANNEL KIR4.1; MEDICAL RESEARCH; NEPHROTOXICITY; NONHUMAN; PROTEIN FUNCTION; REVIEW; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; SYMPTOMATOLOGY; TISSUE INJURY;

EID: 26244438716     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i34.5259     Document Type: Review

References (68)

1. + and Cl- conductances in apical membrane vesicles from stimulated rabbit oxyntic cells. Am J Physiol 1990; 259(5 Pt 1): G850-858
2. Rabon E, Chang H, Sachs G. Quantitation of hydrogen ion and potential gradients in gastric plasma membrane vesicles. Biochemistry 1978; 17: 3345-3353
3. Ganser AL, Forte JG. K + -stimulated ATPase in purified microsomes of bullfrog oxyntic cells. Biochim Biophys Acta 1973; 307: 169-180
4. Sachs G, Chang HH, Rabon E, Schackman R, Lewin M, Saccomani G. A nonelectrogenic H+ pump in plasma membranes of hog stomach. J Biol Chem 1976; 251: 7690-7698
5. Wallmark B, Stewart HB, Rabon E, Saccomani G, Sachs G. The catalytic cycle of gastric (H+ + K+)-ATPase. J Biol Chem 1980; 255: 5313-5319
6. MacLennan DH, Brandl CJ, Korczak B, Green NM. Amino-acid sequence of a Ca2+ + Mg2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. Nature 1985; 316: 696-700
7. Shull GE, Schwartz A, Lingrel JB. Amino-acid sequence of the catalytic subunit of the (Na+ + K+)ATPase deduced from a complementary DNA. Nature 1985; 316: 691-695
8. Crowson MS, Shull GE. Isolation and characterization of a cDNA encoding the putative distal colon H+,K(+)-ATPase. Similarity of deduced amino acid sequence to gastric H+,K (+)-ATPase and Na+,K(+)-ATPase and mRNA expression in distal colon, kidney, and uterus. J Biol Chem 1992; 267: 13740-13748
9. Cuppoletti J, Sachs G. Regulation of gastric acid secretion via modulation of a chloride conductance. J Biol Chem 1984; 259: 14952-14959
10. Wolosin JM. Ion transport studies with H+-K+-ATPase-rich vesicles: implications for HCl secretion and parietal cell physiology. Am J Physiol 1985; 248(6 Pt 1): G595-607
11. Muallem S, Burnham C, Blissard D, Berglindh T, Sachs G. Electrolyte transport across the basolateral membrane of the parietal cells. J Biol Chem 1985; 260: 6641-6653
12. Paradiso AM, Townsley MC, Wenzl E, Machen TE. Regulation of intracellular pH in resting and in stimulated parietal cells. Am J Physiol 1989; 257(3 Pt 1): C554-561
13. Malinowska DH, Kupert EY, Bahinski A, Sherry AM, Cuppoletti J. Cloning, functional expression, and characterization of a PKA-activated gastric Cl- channel. Am J Physiol 1995; 268(1 Pt 1): C191-200
14. Sachs G, Shin JM, Briving C, Wallmark B, Hersey S. The pharmacology of the gastric acid pump: the H+,K+ ATPase. Annu Rev Pharmacol Toxicol 1995; 35: 277-305
15. Smolka A, Helander HF, Sachs G. Monoclonal antibodies against gastric H+ + K+ ATPase. Am J Physiol 1983; 245: G589-596
16. Kasbekar DK, Forte GM, Forte JG. Phospholipid turnover and ultrastructural changes in resting and secreting bullfrog gastric mucosa. Biochim Biophys Acta 1968; 163: 1-13
17. Forte TM, Machen TE, Forte JG. Ultrastructural changes in oxyntic cells associated with secretory function: a membrane-recycling hypothesis. Gastroenterology 1977; 73: 941-955
18. Vagin O, Munson K, Denevich S, Sachs G. Inhibition kinetics of the gastric H,K-ATPase by K-competitive inhibitor SCH28080 as a tool for investigating the luminal ion pathway. Ann N Y Acad Sci 2003; 986: 111-115
19. Rabon EC, Smillie K, Seru V, Rabon R. Rubidium occlusion within tryptic peptides of the H,K-ATPase. J Biol Chem 1993; 268: 8012-8018
20. Swarts HG, Hermsen HP, Koenderink JB, Schuurmans Stekhoven FM, de Pont JJ. Constitutive activation of gastric H+, K+-ATPase by a single mutation. Embo J 1998; 17: 3029-3035
21. Reenstra WW, Forte JG. H+/ATP stoichiometry for the gastric (K+ + H+)-ATPase. J Membr Biol 1981; 61: 55-60
22. Rabon EC, McFall TL, Sachs G. The gastric [H,K]ATPase: H+/ATP stoichiometry. J Biol Chem 1982; 257: 6296-6299
23. Skrabanja AT, de Pont JJ, Bonting SL. The H+/ATP transport ratio of the (K+ + H+)-ATPase of pig gastric membrane vesicles. Biochim Biophys Acta 1984; 774: 91-95
24. Koenderink JB, Swarts HG, Willems PH, Krieger E, de Pont JJ. A conformation-specific interhelical salt bridge in the K+ binding site of gastric H,K-ATPase. J Biol Chem 2004; 279: 16417-16424
25. Bukrinsky JT, Buch-Pedersen MJ, Larsen S, Palmgren MG. A putative proton binding site of plasma membrane H(+)-ATPase identified through homology modelling. FEBS Lett 2001; 494: 6-10
26. Munson KB, Gutierrez C, Balaji VN, Ramnarayan K, Sachs G. Identification of an extracytoplasmic region of H+,K(+)-ATPase labeled by a K(+)-competitive photoaffinity inhibitor. J Biol Chem 1991; 266: 18976-18988
27. Swarts HG, Klaassen CH, de Boer M, Fransen JA, de Pont JJ. Role of negatively charged residues in the fifth and sixth transmembrane domains of the catalytic subunit of gastric H+, K+-ATPase. J Biol Chem 1996; 271: 29764-29772
28. Vagin O, Munson K, Lambrecht N, Karlish SJ, Sachs G. Mutational analysis of the K+-competitive inhibitor site of gastric H,K-ATPase. Biochemistry 2001; 40: 7480-7490
29. Asano S, Tega Y, Konishi K, Fujioka M, Takeguchi N. Functional expression of gastric H+,K(+)-ATPase and site-directed mutagenesis of the putative cation binding site and catalytic center. J Biol Chem 1996; 271: 2740-2745
30. Munson K, Lambrecht N, Shin JM, Sachs G. Analysis of the membrane domain of the gastric H(+)/K(+)-ATPase. J Exp Biol 2000; 203(Pt 1): 161-170
31. Gatto C, Lutsenko S, Shin JM, Sachs G, Kaplan JH. Stabilization of the H,K-ATPase M5M6 membrane hairpin by K+ ions. Mechanistic significance for p2-type atpases. J Biol Chem 1999; 274: 13737-13740
32. de Pont JJ, Swarts HG, Willems PH, Koenderink JB. The E1/E2-preference of gastric H,K-ATPase mutants. Ann N Y Acad Sci 2003; 986: 175-182
33. Lorentzon P, Sachs G, Wallmark B. Inhibitory effects of cations on the gastric H+, K+ -ATPase. A potential-sensitive step in the K+ limb of the pump cycle. J Biol Chem 1988; 263: 10705-10710
34. Fryklund J, Gedda K, Scott D, Sachs G, Wallmark B. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands. Am J Physiol 1990; 258(5 Pt 1): G719-727
35. Mense M, Rajendran V, Blostein R, Caplan MJ. Extracellular domains, transmembrane segments, and intracellular domains interact to determine the cation selectivity of Na,K- and gastric H,K-ATPase. Biochemistry 2002; 41: 9803-9812
36. Koenderink JB, Swarts HG, Hermsen HP, de Pont JJ. The beta-subunits of Na+,K+-ATPase and gastric H+,K+-ATPase have a high preference for their own alpha-subunit and affect the K+ affinity of these enzymes. J Biol Chem 1999; 274: 11604-11610
37. Hermsen HP, Swarts HG, Wassink L, Dijk FJ, Raijmakers MT, Klaassen CH, Koenderink JB, Maeda M, De Pant JJ. The K(+) affinity of gastric H(+),K(+)-ATPase is affected by both lipid composition and the beta-subunit. Biochim Biophys Acta 2000; 1480: 182-190
38. Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, Moreno H, Nadal MS, Ozaita A, Pountney D, Saganich M, Vega-Saenz de Miera E, Rudy B. Molecular diversity of K+ channels. Ann N Y Acad Sci 1999; 868: 233-285
39. Dedek K, Waldegger S. Colocalization of KCNQ1/KCNE channel subunits in the mouse gastrointestinal tract. Pflugers Arch 2001; 442: 896-902
40. Grahammer F, Herling AW, Lang HJ, Schmitt-Graff A, Wittekindt OH, Nitschke R, Bleich M, Barhanin J, Warth R. The cardiac K+ channel KCNQ1 is essential for gastric acid secretion. Gastroenterology 2001; 120: 1363-1371
41. Malinowska DH, Sherry AM, Tewari KP, Cuppoletti J. Gastric parietal cell secretory membrane contains PKA- and acid-activated Kir2.1 K+ channels. Am J Physiol Cell Physiol 2004; 286: C495-506
42. Lee MP, Ravenel JD, Hu RJ, Lustig LR, Tomaselli G, Berger RD, Brandenburg SA, Litzi TJ, Banton TE, Limb C, Francis H, Gorelikow M, Gu H, Washington K, Argani P, Goklenriny JR, Coffey RJ, Feinberg AP. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest 2000; 106: 1447-1455
43. Fujita A, Horio Y, Higashi K, Mouri T, Hata F, Takeguchi N, Kurachi Y. Specific localization of an inwardly rectifying K(+) channel, Kir4.1, at the apical membrane of rat gastric parietal cells; its possible involvement in K(+) recycling for the H(+)-K (+)-pump. J Physiol 2002; 540: 85-92
44. Supplisson S, Loo DD, Sachs G. Diversity of K+ channels in the basolateral membrane of resting Necturus oxyntic cells. J Membr Biol 1991; 123: 209-221
45. Raap M, Biedermann B, Braun P, Milenkovic I, Skatchkov SN, Bringmann A, Reichenbach A. Diversity of Kir channel subunit mRNA expressed by retinal glial cells of the guinea-pig. Neurorepor 2002; 13: 1037-1040
46. Wulfsen I, Hauber HP, Schiemann D, Bauer CK, Schwarz JR. Expression of mRNA for voltage-dependent and inward-rectifying K channels in GH3/B6 cells and rat pituitary. J Neuroendocrinol 2000; 12: 263-272
47. Higashi K, Fujita A, Inanobe A, Tanemoto M, Doi K, Kubo T, Kurachi Y. An inwardly rectifying K(+) channel, Kir4.1, expressed in astrocytes surrounds synapses and blood vessels in brain. Am J Physiol Cell Physiol 2001; 281: C922-931
48. Vakil N. Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 19: 1041-1049
49. Ene MD, Khan-Daneshmend T, Roberts CJ. A study of the inhibitory effects of SCH 28080 on gastric secretion in man. Br J Pharmacol 1982; 76: 389-391
50. Lambrecht N, Munson K, Vagin O, Sachs G. Comparison of covalent with reversible inhibitor binding sites of the gastric H,K-ATPase by site-directed mutagenesis. J Biol Chem 2000; 275: 4041-4048
51. Asano S, Matsuda S, Hoshina S, Sakamoto S, Takeguchi N. A chimeric gastric H+,K+-ATPase inhibitable with both ouabain and SCH 28080. J Biol Chem 1999; 274: 6848-6854
52. Keeling DJ, Taylor AG, Schudt C. The binding of a K+ competitive ligand, 2-methyl,8-(phenylmethoxy)imidazo(1,2-a) pyridine 3-acetonitrile, to the gastric (H+ + K+)-ATPase. J Biol Chem 1989; 264: 5545-5551
53. Mendlein J, Sachs G. Interaction of a K(+)-competitive inhibitor, a substituted imidazo[1,2a] pyridine, with the phospho- and dephosphoenzyme forms of H+, K(+)-ATPase. J Biol Chem 1990; 265: 5030-5036
54. Yan D, Hu YD, Li S, Cheng MS. A model of 3D-structure of H+, K+-ATPase catalytic subunit derived by homology modeling. Acta Pharmacol Sin 2004; 25: 474-479
55. Asano S, Yoshida A, Yashiro H, Kobayashi Y, Morisato A, Ogawa H, Takeguchi N, Morii M. The cavity structure for docking the K(+)-competitive inhibitors in the gastric proton pump. J Biol Chem 2004; 279: 13968-13975
56. Martinek J, Blum AL, Stolte M, Hartmann M, Verdu EF, Luhmann R, Dorta G, Wiesel P. Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1999; 13: 27-34
57. Keeling DJ, Malcolm RC, Laing SM, Ife RJ, Leach CA. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase. Biochem Pharmacol 1991; 42: 123-130
58. Tsukimi Y, Ushiro T, Yamazaki T, Ishikawa H, Hirase J, Narita M, Nishigaito T, Banno K, Ichihara T, Tanaka H. Studies on the mechanism of action of the gastric H+,K(+)-ATPase inhibitor SPI-447. Jpn J Pharmacol 2000; 82: 21-28
59. Wallmark B, Briving C, Fryklund J, Munson K, Jackson R, Mendlein J, Rabon E, Sachs G. Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole. J Biol Chem 1987; 262: 2077-2084
60. Wurst W, Hartmann M. Current status of acid pump antagonists (reversible PPIs). Yale J Biol Med 1996; 69: 233-243
61. +-ATPase selective, potassium-competitive acid blocker. Gastroenterology 2004; 126: A333
62. Holstein B, Holmberg A, Florentzson M, Holmberg AA, Andersson M, Andersson K. AZD0865 - a new potassium-competitive acid blocker-exhibits maximal gastric antisecretory effects from first dose. Gastroenterology 2004; 126: A334
63. Andersson K, Holmberg AA, Briving C, Holstein B. Preclinical profile of AZD0865, a novel, selective, potassium-competitive acid blocker. Gastroenterology 2004; 126: A56
64. Park S, Ahn B, Lee B, Kang H, Song K. Pharmacokinetics of YH1885. Gut 2003: 52(Suppl 6): A62
65. Park S, Lee S, Song K, Lee B, Kang H, Kang J. The pharmacological properties of a novel acid pump antagonist, YH1885. Gut 2003; 52(Suppl 6): A62
66. Yu KS, Bae KS, Shon JH, Cho JY, Yi SY, Chung JY, Lim HS, Jang JJ, Shins G, Song KS, Moon BS. Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers. J Clin Pharmacol 2004; 44: 73-82
67. Kromer W, Postius S, Riedel R. Animal pharmacology of reversible antagonism of the gastric acid pump, compared to standard antisecretory principles. Pharmacology 2000; 60: 179-187
68. Pope AJ, Sachs G. Reversible inhibitors of the gastric (H+/K+)-ATPase as both potential therapeutic agents and probes of pump function. Biochem Soc Trans 1992; 20: 566-572